AddLife publishes prospectus supplement regarding the rights issue
The prospectus supplement regarding the rights issue in AddLife AB (publ), reg. no. 556995-8126 (“AddLife”), has been approved and registered by the Swedish Financial Supervisory Authority and is now available at AddLife’s website, www.add.life, and at Handelsbanken’s website for investment offers, www.handelsbanken.se/investeringserbjudande. The prospectus supplement will also, in a few days, be made available at the Swedish Financial Supervisory Authority’s website www.fi.se. Please find the prospectus supplement at www.add.life/en/investors/financial-reports-and-presentations/